Aurora Cannabis Inc.

ACB

CA05156X8504

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 04:00:00 2025-03-14 pm EDT			5-day change	1st Jan Change
6.340 ^CAD	+2.26%		-7.58%	+3.76%

Feb. 21	Aurora Cannabis Expands Product Portfolio in Australia	MT
Feb. 20	Aurora Cannabis Brief: Expanding Medical Cannabis Pastille Offerings in Australia	MT

Canaccord Genuity Upgrades Aurora Cannabis to Buy From Hold

February 09, 2024 at 10:14 am EST

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Aurora Cannabis Inc.

Aurora Cannabis Expands Product Portfolio in Australia	Feb. 21	MT
Aurora Cannabis Brief: Expanding Medical Cannabis Pastille Offerings in Australia	Feb. 20	MT
Aurora Cannabis Inc. Expands Medical Cannabis Pastille Offerings in Australia	Feb. 20	CI
Aurora Cannabis Eases Patient Access to Medical Cannabis Products in Australia, Files Short Form Base Shelf Prospectus	Feb. 18	MT
Aurora Cannabis Inc. in Conjunction with MedReleaf Australia Eases Patient Access to High Quality Medical Cannabis Products in Australia	Feb. 14	CI
Aurora Cannabis Files For Mixed Shelf Of Up To $250 Million	Feb. 14	RE
Aurora Cannabis Signs Supply Agreement With SNDL	Feb. 07	MT
Aurora Cannabis Brief: Announced Overnight Supply Agreement With SNDL	Feb. 07	MT
Aurora Cannabis Announces Supply Agreement With SNDL	Feb. 06	RE
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading	Feb. 05	MT
Top Midday Gainers	Feb. 05	MT
Toronto Stocks Advance; Finning International Rises on 4Q Profit, Revenue Beats	Feb. 05	DJ
Aurora Cannabis Up 17% in Pre-market Trading After Reporting Swing to Q3 Profit	Feb. 05	MT
Aurora Cannabis Inc., Q3 2025 Earnings Call, Feb 05, 2025	Feb. 05
Aurora Cannabis Announces Fiscal 2025 Third Quarter Results	Feb. 05	RE
Aurora Cannabis Inc. Reports Unaudited Consolidated Impairment of Property, Plant and Equipment for the Third Quarter Ended December 31, 2024	Feb. 05	CI
Aurora Cannabis Brief: Adds Maintained Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business	Feb. 05	MT
Aurora Cannabis Brief: Says Achieved Target of Positive Free Cash Flow in Q3, Generating $27.4 Million of Free Cash Flow	Feb. 05	MT
Aurora Cannabis Brief: Says Generated Q3 Record Net Income of $31.2 Million, and Record Adjusted EBITDA of $23.1 Million	Feb. 05	MT
Aurora Cannabis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	Feb. 05	CI
Aurora Cannabis Brief: Reporting Total Net Revenue of $88.2 Million	Feb. 05	MT
Aurora Launching Medical Cannabis Brand in Germany	Jan. 23	MT
Aurora Cannabis Up 0.25% In US Premarket As Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License	Jan. 23	MT
Aurora Cannabis Announces Distribution Partnership for Medical Cannabis Products in Australia	Dec. 17	MT
Aurora Cannabis Brief: Announcing Distribution Partnership Between MedReleaf Australia and The Entourage Effect	Dec. 17	MT

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Companyâs principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Employees

1,073

Sector

Pharmaceuticals

Calendar

Jun. 18 - Q4 2025 Earnings Release (Projected)

More about the company